Search

Search Constraints

You searched for: Record Type Journal Article

Search Results

7. Neither vaginal nor buccal administration of 800 μg misoprostol alters mucosal and systemic immune activation or the cervicovaginal microbiome: a pilot study. (1st November 2016)